Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/recent-developments-in-adjuvant-chemotherapy-for-colorectal-cancer-Le83RXvOIz
References (29)
-
M. Poon, M. O’connell, C. Moertel, H. Wieand, S. Cullinan, L. Everson, J. Krook, J. Mailliard, J. Laurie, L. Tschetter (1989)
Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 7 10
-
NIH consensus conference: Adjuvant therapy for patients with colon and rectal cancer
JAMA, 264
-
Zaniboni Zaniboni, Boffi Boffi, Arcangeli Arcangeli (1996)
The S.M.A.C. study: large scale collaborative trial of adjuvant therapy in colon cancer‐feasibility analysisProceedings of American Society of Clinical Oncology, 15
-
G. Francini, R. Petrioli, L. Lorenzini, S. Mancini, S. Armenio, G. Tanzini, S. Marsili, A. Aquino, G. Marzocca, S. Civitelli, L. Mariani, D. Sando, S. Bovenga, Marco Lorenzi (1994)
Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer.Gastroenterology, 106 4
-
Laffer Laffer, Metzger Metzger, Aberhard Aberhard (1995)
Long term results of single course of adjuvant intraportal chemotherapy for colorectal cancerLancet, 345
-
Cunningham Cunningham, Zalcberg Zalcberg, Rath Rath (1995)
Tomudex (ZD1694); Results of a randomised trial in advanced cancer demonstrates efficacy and reduced muscositis and leucopeniaEuropean Journal of Cancer, 31
-
D. Cunningham, Zalcberg, U. Rath, Ian Olver, E. VanCutsem, C. Svensson, Jean-François Seitz, P. Harper, D. Kerr, G. Pérez-Manga (1995)
'Tomudex' (ZD1694): results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. The 'Tomudex' Colorectal Cancer Study Group.European journal of cancer, 31A 12
-
Gray Gray, James James, Mossman Mossman (1991)
AXIS: a suitable case for treatmentBritish Journal of Cancer, 63
-
P. Piedbois (1992)
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 10 6
-
Nanette Gordon, Audrey Dawson, Bruce Bennett, George Innes, Oleg Eremin, Peter Jones (1993)
Outcome in colorectal adenocarcinoma: two seven-year studies of a population.British Medical Journal, 307
-
N. Wolmark, B. Fisher, H. Rockette, C. Redmond, D. Wickerham, E. Fisher, Judy Jones, A. Glass, H. Lerner, W. Lawrence (1988)
Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01.Journal of the National Cancer Institute, 80 1
-
M. Slevin, R. Gray (1991)
Adjuvant therapy for cancer of the colon.British Medical Journal, 302
-
Wolmark Wolmark, Rjockette Rjockette, Fisher Fisher (1993)
The benefit of leucovorin‐modulated fluorouracil as postoperative adjuvant therapy for primary colon cancerJournal of Clinical Oncology, 11
-
Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
Lancet, 345
-
L. Hunt, N. Armitage, M. Dunlop (1992)
Screening for large bowel neoplasms individuals with a family history of colorectal cancerBritish Journal of Surgery, 79
-
R. Gray, R. James, J. Mossman, S. Stenning, on Subcommittee (1991)
AXIS--a suitable case for treatment. UK Coordinating Committee on Cancer Research (UKCCCR) Colorectal Cancer Subcommittee.British Journal of Cancer, 63
-
Finlay Finlay, McArdle McArdle (1986)
Occult hepatic metastases in colorectal carcinomaBritish Journal of Surgery, 73
-
Slevin Slevin, Gray Gray (1991)
Adjuvant therapy for cancer of the colon: An important step forwardBritish Medical Journal, 302
-
M. Teixeira, N. Pandis, G. Bardi, J. Andersen, F. Mitelman, S. Heim (1995)
Clonal heterogeneity in breast cancer: Karyotypic comparisons of multiple intra—and extra—tumorous samples from 3 patientsInternational Journal of Cancer, 63
-
C. Moertel, T. Fleming, J. Macdonald, D. Haller, J. Laurie, P. Goodman, J. Ungerleider, W. Emerson, D. Tormey, J. Glick, M. Veeder, J. Mailliard (1990)
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.The New England journal of medicine, 322 6
-
M. Buyse, A. Zeleniuch‐Jacquotte, T. Chalmers (1988)
Adjuvant therapy of colorectal cancer. Why we still don't know.JAMA, 259 24
-
F. Smedley, M. Taube, J. Gilbert (1986)
Tens after hernia repairBritish Journal of Surgery, 73
-
Piedbois Piedbois, Buyse Buyse, Rustum Rustum
on behalf of the Advanced Colorectal Meta‐analysis Project. (1992) Modulation of fluorouracil by leuconvorin in patients with advanced colorectal cancer: Evidence intermsof response rateJournal of Clinical Oncology, 10
-
N. Wolmark, H. Rockette, B. Fisher, D. Wickerham, C. Redmond, Edwin Fisher, J. Jones, E. Mamounas, L. Ore, N. Petrelli (1993)
The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 11 10
-
Berrino Berrino, Sant Sant, Verdecchia Verdecchia (1995)
Survival of cancer patients in Europe: the Eurocare studyInternational Journal of Cancer, 63
-
J. Wils, D. Wagener (1990)
Adjuvant treatment of colon cancer: where to go from here?Annals of oncology : official journal of the European Society for Medical Oncology, 1 5
-
C. Dukes (1980)
The classification of cancer of the rectumDiseases of the Colon & Rectum, 23
-
Dukes Dukes (1932)
The classification of cancer of the rectumJ Pathol, 63
-
Wolmark Wolmark, Rockette Rockette, Marnounas Marnounas (1996)
The relative efficacy of 5FU+leucovorin(FU‐LV), 5FU+levamisole (FU‐Lev) and 5FU+leucovorin+levamisole (FU‐LV‐LEV) in patients with Dukes' B and C carcinoma of the colon: first report of NSABP C‐04American Society of Clinical Oncology (ASCO), 15
- Publisher
- Wiley
- Copyright
- Copyright © 1997 Wiley Subscription Services, Inc., A Wiley Company
- ISSN
- 0961-5423
- eISSN
- 1365-2354
- DOI
- 10.1111/j.1365-2354.1997.tb00264.x
- Publisher site
- See Article on Publisher Site
Abstract
Recent developments in the use of systemic chemotherapy and intraportal dchemotherapy in the treatment for colorectal cancer suggests that a reduction in mortality is achievable. This paper provides an overview of the management of colorectal cancer and the rationale behind adjuvant chemotherapy. A review of the current research literature published from both America and Europe will follow. Finally, the limitations and implications of the reviewed data will be discussed.
Journal
European Journal of Cancer Care – Wiley
Published: Mar 1, 1997